Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Akira Umeda, Tateki Yamane, Taichi Mochizuki, Yasushi Inoue, Kenji Tsushima, Kazuya Miyagawa, Atsumi Mochida, Hiroshi Takeda, Yasumasa Okada & Koich Fukunaga. (2019) Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma. Cogent Medicine 6:1.
Read now
Read now
Articles from other publishers (2)
A. A. Viesel & I. Yu. Viesel. (2022) Fixed combination of vilanterol triphenatate/fluticasone furoate in the treatment of patients with bronchial asthma and chronic obstructive pulmonary disease: a literature review. Meditsinskiy sovet = Medical Council:21-1, pages 72-78.
Crossref
Crossref
Henrik Svedsater, Helen A. Doll, Jake Macey, Gail Miles, Lisa Bradshaw & Magdalena Vanya. (2018) Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences. Advances in Therapy 35:9, pages 1378-1399.
Crossref
Crossref